Shortage of injectable telavancin

The American Society of Health-System Pharmacists reports a shortage of injectable telavancin. This drug shortage is important to you if your skin and the surrounding connective tissue becomes infected with one of the bacteria that destroys the tissue structure. The best-known is Staphylococcus aureus. Other members of this group are Streptococcus pyogenes, Streptococcus agalactiae, the Streptococcus anginosus group, and Enterococcus faecalis. If vancomycin doesn't work, telavancin is a derivative of vancomycin to which some bacteria might be sensitive. These are life-threatening infections which occasionally require heroic measures, including amputation of a limb in order to save your life.

The reasons for the shortage given in the ASHP bulletin are clear in this instance. There is no foreseeable date at which this antibiotic might become available.